Physicians Say MIGs Is Transforming Glaucoma Treatment
Ike K. Ahmed, MD, led a discussion between three notable ophthalmologists treating glaucoma patients with MIGs. The panel followed a presentation by Ahmed and four companies leading the MIGS space. Panelists include Robert Cionni, MD, Richard Lewis, MD and Jai G. Parekh, MD, MBA.
00:20 – What are your thoughts on the growth of the combined cataract-glaucoma market?
00:32 – Cionni: Thinks the combination is exciting, but looks forward to working on patients who just need glaucoma treatment.
01:15 – Lewis: Younger glaucoma surgeons adapting to MIGS.
0:140 – Active endophthalmitis is a `ticking time bomb’ with trabeculectomy.
02:10 – Parekh says this is a great time to be performing MIGS. The d
02:17 – “The days of poly-pharma in glaucoma, and tubes and trabs, are over. It’s on life support.”
02:36 – Decoupling the procedure from cataract surgery will allow surgeons to intervene more quickly.
03:00 – What is the market adopting going to be on the clinician side.
03:30 – Parekh says 40% of his practice in Northern New Jersey is glaucoma. “In our area, I was one of the first to do MIGS…now so many surgeons are doing MIGS.”
04:30 – Lewis says so much technology is coming; ophthalmologists must keep up. Patients come to office asking for latest technology. “Patients are much more aware and they are going to force the issue.”
05:45 – Says iStent had a learning curve, but procedure is very simple.
Ike Ahmed, MD
Dr. Ahmed is currently Assistant Professor at the University of Toronto and Professor at the University of Utah.
Robert Cionni, MD
Dr. Robert J. Cionni, Medical Director of The Eye Institute of Utah is a world renowned authority and pioneer in the field of modern cataract surgery.
Richard Lewis, MD
Richard A. Lewis, M.D. is the former director of glaucoma at the University of California, Davis. In addition to his busy clinical practice located in Sacramento, California, Dr. Lewis is actively involved in clinical research in national and international trials in anterior segment disease and glaucoma therapy.
Jai G. Parekh, MD, MBA
Jai G. Parekh, MD, MBA, FAAO, is a board-certified anterior segment surgeon in the NJ/NY area. He is the managing-partner at Brar-Parekh Eye Associates, NJ, and Clinical Associate Professor of Ophthalmology at the New York Eye & Ear Infirmary/The Icahn School of Medicine at Mt. Sinai.